EZH2 and cancer: Notably, epigenetic mechanism was also shown to be involved in partial EMT, where inactive EZH2 in FAT1-mutated skin squamous cell carcinoma and lung cancer cells reduced the inhibitory action of H3K27me3 on the promoter of SOX2, contributing to the epithelial phenotype of cancer cells in hybrid EMT state (34).